Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 20:00
Lakefront Biotherapeutics Gross Profit Margin (Quarterly) : 24.48% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.48% |
| March 31, 2026 | 25.95% |
| December 31, 2025 | 99.95% |
| September 30, 2025 | 84.76% |
| June 30, 2025 | 92.79% |
| March 31, 2025 | 81.69% |
| December 31, 2024 | 79.15% |
| September 30, 2024 | 99.97% |
| June 30, 2024 | 78.74% |
| March 31, 2024 | 95.92% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 72.82% |
| September 30, 2022 | 93.93% |
| June 30, 2022 | 74.50% |
| March 31, 2022 | 93.82% |
| December 31, 2021 | 96.07% |
| September 30, 2021 | 86.63% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 98.61% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 87.72% |
| September 30, 2015 | 0.00% |
| December 31, 2005 | -10.54% |
| September 30, 2005 | -218.1% |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | 0.00% |
| September 30, 2004 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alkermes Plc | 75.30% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Amarin Corp. Plc | 34.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.02% |
| Return on Assets | 16.99% |
| Return on Invested Capital | 19.97% |
| Profit Margin (Quarterly) | 16.05% |
| Operating Margin (Quarterly) | -372.1% |
| Return on Net Operating Assets | 176.9% |